A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

S. Salloway, R. Sperling, R. Keren, A. P. Porsteinsson, C. H. Van Dyck, P. N. Tariot, S. Gilman, D. Arnold, S. Abushakra, C. Hernandez, G. Crans, E. Liang, G. Quinn, M. Bairu, A. Pastrak, J. M. Cedarbaum

Research output: Contribution to journalArticlepeer-review

215 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease'. Together they form a unique fingerprint.

Medicine & Life Sciences